건강검진 시장 기회, 성장요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Health Check-up Market was valued at USD 61.5 billion in 2025 and is estimated to grow at a CAGR of 6.5% to reach USD 116 billion by 2035.

Growth in the health check-up market is driven by rising investments in population health screening initiatives, increasing prevalence of chronic diseases, and greater public awareness regarding the importance of early disease detection. A health check-up refers to a comprehensive medical evaluation conducted by trained healthcare professionals to assess an individual's overall health status. These examinations are designed to identify potential health risks, detect early signs of medical conditions, and provide recommendations for preventive care. Governments and healthcare institutions across several regions are increasingly implementing policies that encourage preventive health services through regular medical examinations. Such initiatives aim to reduce the long-term economic burden associated with advanced-stage diseases by promoting early diagnosis and timely treatment. In addition, many organizations are integrating health screening services into employee wellness initiatives designed to support workforce health and improve productivity. These programs encourage regular medical assessments that help identify health risks early and support long-term wellbeing. Together, these factors are significantly contributing to the expansion of the global health check-up market.

The routine and wellness health check-up segment generated USD 18.3 billion in 2025 and is expected to reach USD 33.1 billion by 2035. Increasing awareness of lifestyle-related health risks is encouraging individuals to participate in regular medical screenings designed to monitor overall wellness and detect potential health concerns at an early stage. In addition, the growing availability of cost-effective wellness packages, the expansion of digital appointment scheduling platforms, and the rising popularity of personalized preventive health programs are supporting continued growth in this segment throughout the forecast period.

The complete blood count test segment is anticipated to grow at a CAGR of 6.1% and is projected to reach USD 25.5 billion by 2035. This diagnostic test plays an important role in evaluating an individual's health by analyzing different types of blood cells and their concentrations. Medical professionals rely on this test to assess various aspects of physiological health, including indicators that support the identification of nutritional imbalances and other underlying health conditions. In addition, variations in blood cell levels can provide valuable insights that assist healthcare providers in recognizing potential infections or inflammatory responses, enabling timely clinical evaluation and appropriate medical management.

United States Health Check-up Market was valued at USD 20.2 billion in 2025 and is projected to grow at a CAGR of 5.6% between 2026 and 2035. Increasing awareness regarding proactive health management continues to drive the demand for preventive healthcare services across the country. The rising incidence of chronic health conditions has encouraged both patients and healthcare professionals to prioritize regular medical assessments that support early detection and ongoing health monitoring. In addition, demographic changes and a growing elderly population are increasing the need for more frequent and comprehensive medical evaluations. Technological advancements in diagnostic equipment are also improving the accuracy and efficiency of health assessments, making screening procedures more accessible and encouraging broader participation in routine health examinations.

Major participants operating in the Global Health Check-up Market include Quest Diagnostics, Labcorp, Eurofins, Sonic Healthcare, SYNLAB, Cerba Healthcare, ARUP Laboratories, Exact Sciences, Natera, Inc., GRAIL, OPKO, Q2 Solutions, INNOVA, Trinity Biotech, and UNILABS. Companies operating in the Global Health Check-up Market are adopting a range of strategic initiatives to strengthen their market presence and expand service capabilities. Leading diagnostic service providers are investing in advanced laboratory technologies and digital healthcare platforms to improve the efficiency and accuracy of medical screening services. Many organizations are expanding preventive healthcare packages and personalized health assessment programs to address growing consumer demand for proactive health management. Strategic collaborations with hospitals, healthcare networks, and corporate organizations are helping companies broaden their customer base and enhance service accessibility. Additionally, firms are strengthening their laboratory infrastructure and geographic presence to support large-scale screening programs.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation for any one approach
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key Market Trends
  • 2.2.1 Regional trends
  • 2.2.2 Type trends
  • 2.2.3 Test type trends
  • 2.2.4 Sample type trends
  • 2.2.5 Panel type trends
  • 2.2.6 Service provider trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Surging investments in population screening
    • 3.2.1.2 Increasing prevalence of diseases
    • 3.2.1.3 Rising awareness of preventive healthcare
    • 3.2.1.4 Increasing adoption of digital technology/telemedicine & home-care services
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost associated with screening
    • 3.2.2.2 Lack of awareness and proper infrastructure in underdeveloped regions
  • 3.2.3 Market opportunities
    • 3.2.3.1 AI-driven diagnostic tools and digital health platforms
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape (Driven by Primary Research)
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology landscape (Driven by Primary Research)
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Reimbursement scenario
• 3.7 Gap analysis (Driven by Primary Research)
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Future market trends
• 3.11 Impact of AI and generative AI on the market
• 3.12 Value chain analysis
• 3.13 Health check-up packages outline (Driven by primary research)
• 3.14 Start-up scenario

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
  • 4.3.5 LAMEA
• 4.4 Competitive positioning matrix
• 4.5 Competitive analysis of major market players
• 4.6 Key Developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product type launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 General health check-up
• 5.3 Routine and wellness health check-up
• 5.4 Specialized health check-up
• 5.5 Preventive health check-up

Chapter 6 Market Estimates and Forecast, By Test Type, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Complete blood count test
• 6.3 Blood glucose test
• 6.4 Electrolyte test
• 6.5 Lipid profile test
• 6.6 Hormones & vitamins
• 6.7 Tumor markers
• 6.8 Liver function test
• 6.9 Cardiac biomarkers
• 6.10 Kidney function test
• 6.11 Bone profile test
• 6.12 Other test types

Chapter 7 Market Estimates and Forecast, By Sample Type, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Blood
• 7.3 Urine
• 7.4 Saliva
• 7.5 Other sample types

Chapter 8 Market Estimates and Forecast, By Panel Type, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 Multi-test panels
• 8.3 Single-test panels

Chapter 9 Market Estimates and Forecast, By Service Provider, 2022 - 2035 ($ Mn)

• 9.1 Key trends
• 9.2 Hospital-based laboratories
• 9.3 Standalone laboratories
• 9.4 Ambulatory care centers
• 9.5 Central laboratories
• 9.6 Other service providers

Chapter 10 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 ARUP Laboratories
• 11.2 Cerba Healthcare
• 11.3 Eurofins
• 11.4 Exact Sciences
• 11.5 GRAIL
• 11.6 INNOVA
• 11.7 Labcorp
• 11.8 Natera, Inc.
• 11.9 OPKO
• 11.10 Q2 Solutions
• 11.11 Quest Diagnostics
• 11.12 Sonic Healthcare
• 11.13 SYNLAB
• 11.14 Trinity Biotech
• 11.15 UNILABS